Skip to main content
All lobbying filings

ALKERMES, INC.

ALKERMES, INC. filed a Q1 report for ALKERMES, INC. on April 20, 2026.

Lobbying for ALKERMES, INC.

All filings by ALKERMES, INC. · Everything ALKERMES, INC. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$1,030,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 10

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Medicare/Medicaid

Patient access and maintain six protected classes for bipolar disorders and schizophrenia under Medicare Part D; Policies regarding drug pricing and Most Favored Nations proposals; Medicaid statutory rebate increases;

Health Issues

Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 55509/S. 2903 the Safe Step Act; Awareness of need for transparency and patient access within the 340B program; PDUFA implementation and efficiency improvements at the FDA; Policies impacting pharmaceutical development, reimbursement, and patient access and cost: H.R. 5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 7148 - Consolidated Appropriations Act, 2026; H.R. 1 - One Big Beautiful Bill Act;

Alcohol and Drug Abuse

Expand funding and flexibility to address all substance use disorders: H.R. 4030 - Treatment Continuity Act of 2025

Tariff (miscellaneous tariff bills)

Policies impacting pharmaceutical distribution and manufacturing

 Bills named in this filing 6
  • 119-HR-55509
    Not yet in our database
  • S. 2903
    Safe Step Act
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • H.R. 7148
    Consolidated Appropriations Act, 2026
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 4030
    Treatment Continuity Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem